Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes

Mutagenesis

Volumn 30, Issue 6, 2015, Pages 771-784

  Rieswijk, Linda ^a,b,c   Brauers, Karen J J ^a,b   Coonen, Maarten L J ^a,b,c   Van Breda, Simone G J ^a,b   Jennen, Danyel G J ^a,b,c   Kleinjans, Jos C S ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Universiteitssingel 40   (Netherlands)

^c Netherlands Toxicogenomics Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLOORDIBENZODIOXINE; AFLATOXIN; ARYL HYDROCARBON RECEPTOR AGONIST; BENZO[A]PYRENE; CARCINOGEN; CISPLATIN; CYCLIN D2; CYCLOSPORIN A; MESSENGER RNA; MICRORNA; MMU MICRORNA 503 5P; PIRINIXIC ACID; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION PROFILING; GENOTOXICITY; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ANIMAL; BIOLOGY; CELL TRANSFORMATION; CHEMICALLY INDUCED; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROCEDURES; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATOCYTES; MALE; MICE; MICRORNAS; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84982165933     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gev036     Document Type: Article

References (101)

1. Doll, R. and Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
2. Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W. and Ahr, H. J. (2005) Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res., 575, 61-84.
3. Hochstenbach, K., van Leeuwen, D. M., Gottschalk, R. W., et al. (2012) Transcriptomic fingerprints in human peripheral blood mononuclear cells indicative of genotoxic and non-genotoxic carcinogenic exposure. Mutat. Res., 746, 124-134.
4. van Delft, J. H., van Agen, E., van Breda, S. G., Herwijnen, M. H., Staal, Y. C. and Kleinjans, J. C. (2004) Discrimination of genotoxic from nongenotoxic carcinogens by gene expression profiling. Carcinogenesis, 25, 1265-1276.
5. Mathijs, K., Brauers, K. J., Jennen, D. G., Boorsma, A., van Herwijnen, M. H., Gottschalk, R. W., Kleinjans, J. C. and van Delft, J. H. (2009) Discrimination for genotoxic and nongenotoxic carcinogens by gene expression profiling in primary mouse hepatocytes improves with exposure time. Toxicol. Sci., 112, 374-384.
6. Lee, S. J., Yum, Y. N., Kim, S. C., et al. (2013) Distinguishing between genotoxic and non-genotoxic hepatocarcinogens by gene expression profiling and bioinformatic pathway analysis. Sci. Rep., 3, 2783.
7. Iida, M., Anna, C. H., Holliday, W. M., Collins, J. B., Cunningham, M. L., Sills, R. C. and Devereux, T. R. (2005) Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens. Carcinogenesis, 26, 689-699.
8. Aubrecht, J. and Caba, E. (2005) Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity. Pharmacogenomics, 6, 419-428.
9. Fielden, M. R., Nie, A., McMillian, M., et al.; Predictive Safety Testing Consortium; Carcinogenicity Working Group. (2008) Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. Toxicol. Sci., 103, 28-34.
10. Nie, A. Y., McMillian, M., Parker, J. B., et al. (2006) Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog., 45, 914-933.
11. Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W. and Ahr, H. J. (2004) Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci., 77, 19-34.
12. Scott, D., Galloway, S. M., Marshall, R. R., Ishidate, M., Jr, Brusick, D., Ashby, J. and Myhr, B. C. (1991) International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutat. Res., 257, 147-205.
13. Fielden, M. R., Adai, A., Dunn, R. T., 2nd, et al.; Predictive Safety Testing Consortium, Carcinogenicity Working Group. (2011) Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat. Toxicol. Sci., 124, 54-74.
14. Heijne, W. H., Kienhuis, A. S., van Ommen, B., Stierum, R. H. and Groten, J. P. (2005) Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Rev. Proteomics, 2, 767-780.
15. Olden, K. (2006) Toxicogenomics-a new systems toxicology approach to understanding of gene-environment interactions. Ann. N. Y. Acad. Sci., 1076, 703-706.
16. Plant, N. (2008) Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis? Toxicology, 254, 164-169.
17. Ament, Z., Waterman, C. L., West, J. A., Waterfield, C., Currie, R. A., Wright, J. and Griffin, J. L. (2013) A metabolomics investigation of nongenotoxic carcinogenicity in the rat. J. Proteome Res., 12, 5775-5790.
18. Jennen, D., Ruiz-Aracama, A., Magkoufopoulou, C., Peijnenburg, A., Lommen, A., van Delft, J. and Kleinjans, J. (2011) Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells. BMC Syst. Biol., 5, 139.
19. Hou, J., Lin, L., Zhou, W., et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 19, 232-243.
20. Pineau, P., Volinia, S., McJunkin, K., et al. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl Acad. Sci. USA, 107, 264-269.
21. Izzotti, A. and Pulliero, A. (2014) The effects of environmental chemical carcinogens on the microRNA machinery. Int. J. Hyg. Environ. Health, 217, 601-627.
22. Li, Z., Branham, W. S., Dial, S. L., Wang, Y., Guo, L., Shi, L. and Chen, T. (2010) Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea. BMC Genomics, 11, 609.
23. Yauk, C. L., Jackson, K., Malowany, M. and Williams, A. (2011) Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. Mutat. Res., 722, 131-139.
24. Moffat, I. D., Boutros, P. C., Celius, T., Linden, J., Pohjanvirta, R. and Okey, A. B. (2007) microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol. Sci., 99, 470-487.
25. Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M. and Gonzalez, F. J. (2007) Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol., 27, 4238-4247.
26. Zhang, B. and Pan, X. (2009) RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect., 117, 231-240.
27. Corvi, R., Albertini, S., Hartung, T., Hoffmann, S., Maurici, D., Pfuhler, S., van Benthem, J. and Vanparys, P. (2008) ECVAM retrospective validation of in vitro micronucleus test (MNT). Mutagenesis, 23, 271-283.
28. Kirkland, D., Kasper, P., Muller, L., Corvi, R. and Speit, G. (2008) Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat. Res., 653, 99-108.
29. Lambert, I. B., Singer, T. M., Boucher, S. E. and Douglas, G. R. (2005) Detailed review of transgenic rodent mutation assays. Mutat. Res., 590, 1-280.
30. Valentin-Severin, I., Le Hegarat, L., Lhuguenot, J. C., Le Bon, A. M. and Chagnon, M. C. (2003) Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays. Mutat. Res., 536, 79-90.
31. Muller-Tegethoff, K., Kasper, P. and Muller, L. (1995) Evaluation studies on the in vitro rat hepatocyte micronucleus assay. Mutat. Res., 335, 293-307.
32. Khynriam, D. and Prasad, S. B. (2003) Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma. Mutat. Res., 526, 9-18.
33. U.S. National Library of Medicine (2014) Toxnet Toxicological Data Network (CCRIS,HSDB, ChemIDplus and Genetox). http://toxnet.nlm.nih. gov/ (accessed on November 14, 2014).
34. Kirkland, D., Reeve, L., Gatehouse, D. and Vanparys, P. (2011) A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat. Res., 721, 27-73.
35. Food and Drug Administration (FDA) (2012) International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice. Fed. Regist., 77, 33748-33749.
36. International Agency for Research on Cancer (IARC) (2014) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. http:// monographs.iarc.fr/ENG/Classification/ClassificationsGroupOrder.pdf (accessed on November 14, 2014).
37. US Department of Health and Human Services (2014) Public Health Service. National Toxicology Program (NTP) (2014) Report on Carcinogens. http://ntp.niehs.nih.gov/pubhealth/roc/roc13/index.html (accessed on November 14, 2014).
38. Reddy, J. K., Rao, M. S., Azarnoff, D. L. and Sell, S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. Cancer Res., 39, 152-161.
39. Mathijs, K., Brauers, K. J., Jennen, D. G., Lizarraga, D., Kleinjans, J. C. and van Delft, J. H. (2010) Gene expression profiling in primary mouse hepatocytes discriminates true from false-positive genotoxic compounds. Mutagenesis, 25, 561-568.
40. Edgar, R., Domrachev, M. and Lash, A. E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
41. Eijssen, L. M., Jaillard, M., Adriaens, M. E., Gaj, S., de Groot, P. J., Muller, M. and Evelo, C. T. (2013) User-friendly solutions for microarray quality control and pre-processing on ArrayAnalysis.org. Nucleic Acids Res., 41, W71-W76.
42. Chen, J. J., Hsueh, H. M., Delongchamp, R. R., Lin, C. J. and Tsai, C. A. (2007) Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data. BMC Bioinformatics, 8, 412.
43. Bourgon, R., Gentleman, R. and Huber, W. (2010) Independent filtering increases detection power for high-throughput experiments. Proc. Natl Acad. Sci. USA, 107, 9546-9551.
44. Magkoufopoulou, C., Claessen, S. M., Tsamou, M., Jennen, D. G., Kleinjans, J. C. and van Delft, J. H. (2012) A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis, 33, 1421-1429.
45. Van den Hof, W. F., Coonen, M. L., van Herwijnen, M., Brauers, K., Wodzig, W. K., van Delft, J. H. and Kleinjans, J. C. (2014) Classification of hepatotoxicants using HepG2 cells: A proof of principle study. Chem. Res. Toxicol., 27, 433-442.
46. Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P. and Mesirov, J. P. (2006) GenePattern 2.0. Nat. Genet., 38, 500-501.
47. Guo, L., Lobenhofer, E. K., Wang, C., et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol., 24, 1162-1169.
48. Kamburov, A., Wierling, C., Lehrach, H. and Herwig, R. (2009) ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res., 37, D623-D628.
49. Kutmon, M., van Iersel, M. P., Bohler, A., Kelder, T., Nunes, N., Pico, A. R. and Evelo, C. T. (2015) PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput. Biol., 11, e1004085.
50. Griffiths-Jones, S., Saini, H. K., van Dongen, S. and Enright, A. J. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res., 36, D154-D158.
51. Hsu, S. D., Lin, F. M., Wu, W. Y., et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res., 39, D163-D169.
52. Nelsen, C. J., Rickheim, D. G., Tucker, M. M., McKenzie, T. J., Hansen, L. K., Pestell, R. G. and Albrecht, J. H. (2003) Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. J. Biol. Chem., 278, 25853-25858.
53. Loyer, P., Cariou, S., Glaise, D., Bilodeau, M., Baffet, G. and Guguen-Guillouzo, C. (1996) Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J. Biol. Chem., 271, 11484-11492.
54. Loyer, P., Ilyin, G., Cariou, S., Glaise, D., Corlu, A. and Guguen-Guillouzo, C. (1996) Progression through G1 and S phases of adult rat hepatocytes. Prog. Cell Cycle Res., 2, 37-47.
55. Awad, M. M. and Gruppuso, P. A. (2000) Cell cycle control during liver development in the rat: evidence indicating a role for cyclin D1 posttranscriptional regulation. Cell Growth Differ., 11, 325-334.
56. Caporali, A. and Emanueli, C. (2011) MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc. Med., 21, 162-166.
57. Forrest, A. R., Kanamori-Katayama, M., Tomaru, Y., et al. (2010) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia, 24, 460-466.
58. Boominathan, L. (2010) The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One, 5, e10615.
59. Pothof, J., Verkaik, N. S., van Ijcken, W., et al. (2009) MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J., 28, 2090-2099.
60. Hu, H. and Gatti, R. A. (2011) MicroRNAs: new players in the DNA damage response. J. Mol. Cell Biol., 3, 151-158.
61. Xiao, F., Zhang, W., Chen, L., et al. (2013) MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. J. Transl. Med., 11, 195.
62. Peters, J. M., Aoyama, T., Cattley, R. C., Nobumitsu, U., Hashimoto, T. and Gonzalez, F. J. (1998) Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis, 19, 1989-1994.
63. Miller, R. T., Glover, S. E., Stewart, W. S., Corton, J. C., Popp, J. A. and Cattley, R. C. (1996) Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643. Carcinogenesis, 17, 1337-1341.
64. Kim, D. W., Gazourian, L., Quadri, S. A., Romieu-Mourez, R., Sherr, D. H. and Sonenshein, G. E. (2000) The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene, 19, 5498-5506.
65. Teoh, N. C., Williams, J., Hartley, J., Yu, J., McCuskey, R. S. and Farrell, G. C. (2010) Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury. Hepatology, 51, 996-1006.
66. Tian, Y., Ke, S., Denison, M. S., Rabson, A. B. and Gallo, M. A. (1999) Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem., 274, 510-515.
67. Barouki, R., Coumoul, X. and Fernandez-Salguero, P. M. (2007) The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett., 581, 3608-3615.
68. Andres, D., Diez-Fernandez, C., Zaragoza, A., Alvarez, A. and Cascales, M. (2001) Induction of cell proliferation by cyclosporine A in primary cultures of rat hepatocytes. Biochem. Pharmacol., 61, 427-435.
69. Salpeter, S. J., Klochendler, A., Weinberg-Corem, N., et al. (2011) Glucose regulates cyclin D2 expression in quiescent and replicating pancreatic β-cells through glycolysis and calcium channels. Endocrinology, 152, 2589-2598.
70. Fajas, L. (2013) Re-thinking cell cycle regulators: the cross-talk with metabolism. Front. Oncol., 3, 4.
71. Ceballos, E., Delgado, M. D., Gutierrez, P., Richard, C., Muller, D., Eilers, M., Ehinger, M., Gullberg, U. and Leon, J. (2000) c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene, 19, 2194-2204.
72. Ho, J. S., Ma, W., Mao, D. Y. and Benchimol, S. (2005) p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol. Cell. Biol., 25, 7423-7431.
73. Webster, G. A. and Perkins, N. D. (1999) Transcriptional cross talk between NF-kappaB and p53. Mol. Cell. Biol., 19, 3485-3495.
74. Zhou, R., Gong, A. Y., Chen, D., Miller, R. E., Eischeid, A. N. and Chen, X. M. (2013) Histone deacetylases and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells in response to microbial challenge by suppressing miR-424 and miR-503. PLoS One, 8, e65153.
75. Jiang, Q., Feng, M. G. and Mo, Y. Y. (2009) Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer, 9, 194.
76. Liao, D. J., Thakur, A., Wu, J., Biliran, H. and Sarkar, F. H. (2007) Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit. Rev. Oncog., 13, 93-158.
77. Mullany, L. K., White, P., Hanse, E. A., et al. (2008) Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle, 7, 2215-2224.
78. Farber, E. (1991) Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Dig. Dis. Sci., 36, 973-978.
79. Wang, S. J. and Gu, W. (2014) To be, or not to be: functional dilemma of p53 metabolic regulation. Curr. Opin. Oncol., 26, 78-85.
80. Maddocks, O. D. and Vousden, K. H. (2011) Metabolic regulation by p53. J. Mol. Med. (Berl)., 89, 237-245.
81. Yeung, S. J., Pan, J. and Lee, M. H. (2008) Roles of p53, MYC and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Cell. Mol. Life Sci., 65, 3981-3999.
82. Kruse, J. P. and Gu, W. (2009) Modes of p53 regulation. Cell, 137, 609-622.
83. Jennen, D. G., Magkoufopoulou, C., Ketelslegers, H. B., van Herwijnen, M. H., Kleinjans, J. C. and van Delft, J. H. (2010) Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol. Sci., 115, 66-79.
84. Maziasz, T. J., Liu, J., Madhu, C. and Klaassen, C. D. (1991) The differential effects of hepatotoxicants on the sulfation pathway in rats. Toxicol. Appl. Pharmacol., 110, 365-373.
85. Funamizu, N., Lacy, C. R., Parpart, S. T., Takai, A., Hiyoshi, Y. and Yanaga, K. (2014) MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. Int. J. Oncol., 44, 725-734.
86. Jiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R. and Schmittgen, T. D. (2008) Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res., 14, 419-427.
87. Shi, W., Gerster, K., Alajez, N. M., et al. (2011) MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res., 71, 2926-2937.
88. Cortez, M. A., Nicoloso, M. S., Shimizu, M., et al. (2010) miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes. Chromosomes Cancer, 49, 981-990.
89. Huang, X., Schwind, S., Yu, B., et al. (2013) Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin. Cancer Res., 19, 2355-2367.
90. Feng, Z., Zhang, C., Wu, R. and Hu, W. (2011) Tumor suppressor p53 meets microRNAs. J. Mol. Cell Biol., 3, 44-50.
91. Xiong, Y., Fang, J. H., Yun, J. P., Yang, J., Zhang, Y., Jia, W. H. and Zhuang, S. M. (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology, 51, 836-845.
92. Lizarraga, D., Gaj, S., Brauers, K. J., Timmermans, L., Kleinjans, J. C. and van Delft, J. H. (2012) Benzo[a]pyrene-induced changes in microRNAmRNA networks. Chem. Res. Toxicol., 25, 838-849.
93. Kim, H. and McCulloch, C. A. (2011) Filamin A mediates interactions between cytoskeletal proteins that control cell adhesion. FEBS Lett., 585, 18-22.
94. Provenzano, P. P. and Keely, P. J. (2011) Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J. Cell Sci., 124, 1195-1205.
95. Du, W. W., Fang, L., Li, M., et al. (2013) MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J. Cell Sci., 126, 1440-1453.
96. Guo, C. J., Pan, Q., Jiang, B., Chen, G. Y. and Li, D. G. (2009) Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis, 14, 1331-1340.
97. Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., Xing, R., Sun, Z. and Zheng, X. (2008) miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res., 36, 5391-5404.
98. Woods, C. G., Burns, A. M., Bradford, B. U., Ross, P. K., Kosyk, O., Swenberg, J. A., Cunningham, M. L. and Rusyn, I. (2007) WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase. Toxicol. Sci., 98, 366-374.
99. Ledda-Columbano, G. M., Pibiri, M., Concas, D., Cossu, C., Tripodi, M. and Columbano, A. (2002) Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli. Hepatology, 36, 1098-1105.
100. Ely, S., Di Liberto, M., Niesvizky, R., Baughn, L. B., Cho, H. J., Hatada, E. N., Knowles, D. M., Lane, J. and Chen-Kiang, S. (2005) Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/ cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Res., 65, 11345-11353.
101. Izzotti, A., Larghero, P., Longobardi, M., Cartiglia, C., Camoirano, A., Steele, V. E. and De Flora, S. (2011) Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat. Res., 717, 9-16.